Gregory, Jason V. http://orcid.org/0000-0002-7964-2027
Kadiyala, Padma
Doherty, Robert
Cadena, Melissa
Habeel, Samer
Ruoslahti, Erkki
Lowenstein, Pedro R.
Castro, Maria G. http://orcid.org/0000-0003-2237-2756
Lahann, Joerg http://orcid.org/0000-0002-3334-2053
Article History
Received: 20 February 2020
Accepted: 16 September 2020
First Online: 10 November 2020
Competing interests
: The University of Michigan has filed a patent application (US 62/931,512) on materials related to the work described in this manuscript. E.R. is a founder, shareholder and officer of DrugCendR, Inc., a company that is developing the iRGD peptide for clinical use.